Glycosylation, the enzymatic conjugation of glycans to proteins, lipids, or RNA molecules, underpins critical biological phenomena such as protein folding, immune recognition, and cell signaling cascades. Despite its essential role in health and disease, the evolutionary genesis of glycosylation pathways has remained shrouded in mystery. This study challenges traditional paradigms by revealing that a significant majority of human GM genes trace back to primordial evolutionary epochs—specifically, the origin of cellular life and the divergence of eukaryotes—thereby positioning glycosylation as a deeply conserved and ancient biochemical process integral to life on Earth.

Focusing on the NG pathway, which predominantly operates within the endoplasmic reticulum (ER) and Golgi apparatus, the researchers uncovered a striking dichotomy in gene origins depending on their subcellular localization. Genes encoding enzymes acting on the cytoplasmic face of the ER demonstrate phylogenetic roots in prokaryotic ancestors, whereas those localized within the ER lumen stem predominantly from eukaryotic evolutionary innovations. This binary evolutionary pattern lends compelling support to the long-hypothesized model that the ER itself originated through an invagination of the prokaryotic inner membrane—a transformative event during eukaryogenesis facilitating the internalization and specialization of cellular compartments.

Utilizing extensive genomic databases—including the Kyoto Encyclopedia of Genes and Genomes (KEGG) and the Carbohydrate Active enZYmes (CAZY) database—the team compiled an exhaustive catalog of GM genes and glycoproteins. They constructed a comprehensive phylogenetic framework comprising 503 representative organisms spanning key taxonomic lineages from the earliest cellular life to Homo sapiens. Through sophisticated bioinformatic analyses employing the blastp algorithm, they probed the evolutionary strata—or phylostrata—at 29 hierarchical taxonomic levels, meticulously charting the temporal emergence of each gene and its functional homologs.

The findings reveal that approximately 56% of GM genes significantly map to the origin of all cellular life, unequivocally positioning glycosylation as a universal, deep-rooted biochemical hallmark shared across the domains of bacteria, archaea, and eukaryotes. An additional 24% of these genes emerge during the advent of eukaryotes, underscoring a critical phase in which glycosylation pathways underwent substantial elaboration concomitant with the rise of cellular complexity. Moreover, around 17% of GM genes are traceable to evolutionary intervals between Amorphea and Bilateria, suggesting that the diversification of animal multicellularity was accompanied by further adaptation and specialization of glycosylation machinery.

Within the ER microenvironment, the spatial genomic distribution of GM genes displays a remarkable evolutionary topography: enzymes localized to the cytoplasmic leaflet predominantly derive from prokaryotic origins, while those functioning within the ER lumen bear the genetic hallmarks of eukaryotic innovation. This spatial partitioning not only supports the invagination theory of ER genesis but also highlights the functional compartmentalization that glycosylation enzymes have undergone as eukaryotic cells evolved intricate internal architectures.

The Golgi apparatus exhibits a similar evolutionary duality in its glycosylation components. Here, glycosidases—enzymes responsible for trimming sugar moieties—largely originate from ancient cellular life, whereas glycosyltransferases, which catalyze the addition of sugar residues, predominantly evolved within eukaryotic lineages. This suggests a sophisticated evolutionary layering where core enzymatic activities essential to glycan processing were inherited from prokaryotic ancestors and subsequently refined by eukaryotic-specific genetic innovations, thereby enhancing the complexity and diversity of glycosylation patterns.

These revelations do not merely satiate academic curiosity; they offer profound implications for biomedical research and therapeutic innovation. By elucidating the evolutionary framework of glycosylation pathways, scientists gain crucial context for understanding how dysregulation in these processes contributes to a host of diseases, ranging from congenital disorders of glycosylation to complex immune pathologies and cancer. This deep evolutionary perspective can facilitate the design of targeted interventions aiming to modulate glycosylation for improved clinical outcomes.

The methodological rigor of this investigation is noteworthy. The integration of multi-source genomic datasets with cutting-edge computational phylogenetics enables a granular reconstruction of evolutionary events with unparalleled precision. Not only does this approach illuminate the ancestral origins of glycosylation genes, but it also charts how gene gain, loss, and functional divergence shaped the modern glycoproteome. Indeed, the enrichment of glycoproteins in more recent evolutionary strata emphasizes their adaptive significance during metazoan and vertebrate evolution, likely reflecting enhanced cellular communication and immune sophistication.

This study’s conceptual model of the ER arising from membrane invagination imbued with ancestral NG pathway components revolutionizes our understanding of organelle evolution. It challenges the conventional view of intracellular compartmentalization as a purely eukaryotic innovation by tracing its roots deep into prokaryotic lineage, thereby bridging cellular evolution across life’s domains. This compelling narrative is further reinforced by spatial activity patterns of glycosylation enzymes across subcellular compartments, presenting a compelling case for evolutionary continuity masked beneath eukaryotic complexity.

The research team’s comprehensive phylogenetic mapping also underscores the importance of multicellularity in driving glycosylation pathway elaboration. The emergence of complex animal body plans necessitated sophisticated glycoprotein functions for cell adhesion, signaling, and immune responses—functions fundamentally dependent on refined glycosylation. Therefore, the evolutionary trajectory traced herein not only illuminates molecular history but also correlates with macroevolutionary trends in animal diversification.

Finally, the implications of this study extend beyond evolutionary biology and biochemistry, offering a fertile ground for translational glycomics. As glycosylation plays a critical role in cell-cell communication and pathogen interactions, understanding its evolutionary architecture can inspire novel vaccine designs, biomarker discovery, and glyco-engineered therapeutics. This work thus marks a crucial step forward in decoding the molecular fabric of life and harnessing its insights for human health.

In conclusion, the paper entitled “Contrasting Macroevolutionary Patterns in the Human N-Glycosylation Pathway” authored by Domagoj Kifer and colleagues presents a paradigm-shifting synthesis of evolutionary genomics and cellular biochemistry. It firmly establishes glycosylation as an ancient, deeply conserved process integral to life’s tapestry and illuminates the evolutionary dynamics that shaped the sophisticated glycosylation machinery characterizing modern eukaryotes. This study not only enriches our fundamental understanding of cell biology but also opens new vistas for biomedical innovation centered on the complex, evolving world of glycobiology.

Subject of Research: Evolutionary origins and diversification of the human N-glycosylation (NG) pathway through phylostratigraphic analysis.

Article Title: Contrasting Macroevolutionary Patterns in the Human N-Glycosylation Pathway

News Publication Date: 17-Feb-2026

Web References:

• Article DOI: https://doi.org/10.1016/j.eng.2025.06.039
• Journal Website: https://www.sciencedirect.com/journal/engineering

Image Credits: Domagoj Kifer et al.

Keywords: Glycosylation, N-glycosylation, Evolution, Endoplasmic Reticulum, Phylostratigraphy, Glycosylation Machinery, Glycoproteins, Eukaryogenesis, Cellular Evolution, Bioinformatics, Glycobiology, ER Evolution

Unlike canonical nucleotide sugar transporters (NSTs), which shuttle glycosylation substrates into organelles such as the Golgi, SLC35B1 demonstrates a distinct substrate specificity and mechanistic profile. Although SLC35B1 shares approximately 30% sequence identity with its closest relative, SLC35B2—a transporter known to import 3′-phosphoadenosine-5′-phosphosulfate into the Golgi—the functions diverge meaningfully. Importantly, biochemical assays have confirmed that SLC35B1 robustly transports ADP and ATP, underscoring its unique role in fueling the ER’s ATP-dependent processes.

The physiological relevance of this transport mechanism cannot be overstated. The ER, as a central hub for protein folding, post-translational modification, and quality control, demands a continuous supply of ATP. The identification of SLC35B1 as the transporter that mediates ATP supply highlights a crucial regulatory node in maintaining ER homeostasis, particularly under conditions of cellular stress when the energy demand surges. This discovery provides a vital piece in the puzzle of how energy metabolism integrates with intracellular trafficking and stress adaptation.

Structurally, SLC35B1 deviates from previously characterized NSTs by exhibiting a narrower and more positively charged substrate cavity on both the luminal and cytoplasmic sides. This adaptation is consistent with the highly negative charge of ATP molecules and reflects how the transporter’s architecture is finely tuned to attract and stabilize such amphipathic substrates. Remarkably, structural analyses reveal that both ADP and the ATP analogue AMP–PNP adopt an unconventional bent conformation within the cytoplasmic-facing cavity. This spatial arrangement diverges from the more open, polar accommodations typical of nucleotide sugar transporters.

This bent conformation poses an intriguing mechanistic challenge: the partial insertion of ATP deep into the cavity restricts the protein’s conformational flexibility. Traditional rocker-switch models for substrate translocation, in which the transporter oscillates smoothly around the substrate, cannot fully explain the dynamics observed in SLC35B1. Instead, the transporter appears to have evolved a highly specialized strategy that incorporates stepwise repositioning of the nucleotide, effectively overcoming spatial constraints while ensuring fidelity and efficiency in transport.

Central to the unique transport mechanism is the differential engagement of the adenine moiety and phosphate groups of ATP with distinct regions within the transporter. The adenine base, characterized by hydrophobicity, initially nests within a hydrophobic patch inside the substrate cavity. This interaction favors repositioning and conformational plasticity as gating helices—specifically transmembrane helices 8 and 9 (TM8–TM9)—close to facilitate substrate translocation. This hydrophobic anchoring contrasts with classical polar substrate binding and may underlie SLC35B1’s relaxed specificity against other nucleotides, a trait potentially tolerable given the high cytoplasmic concentrations of ATP relative to other nucleotides.

The stepwise translocation model further involves a pronounced vertical displacement of the ATP molecule—approximately 6.5 angstroms—enabled by conformational shifts in gating helices. TM9, in particular, undergoes a large rigid-body movement pivoting around an arginine residue (R276) critical for coordinating the α-phosphate of ATP. Concurrently, flexible lysine residues on TM4a and TM4b dynamically adjust to maintain electrostatic interactions with the nucleotide. This coordinated choreography allows SLC35B1 to drive nucleotides across the ER membrane in a controlled, sequential manner.

Importantly, the luminal-facing conformation of SLC35B1 reveals further refined positioning of nucleotides. Here, AMP–PNP and ADP settle into a more canonical binding site at the cavity’s base, suggesting that the return phase of the transport cycle requires nucleotide flipping and repositioning. Electrostatics appear to govern substrate entry from the luminal side, favoring initial phosphate binding that subsequently rearranges to engage the nucleobase. The juxtaposition of hydrophobic surfaces within the luminal cavity facilitates movement of the adenine moiety, supporting the notion of complex intermediate states throughout the transport cycle.

This sophisticated mechanism draws parallels with the mitochondrial ADP/ATP carrier SLC25A4, which is also hypothesized to employ a stepwise translocation strategy for nucleotide movement, despite differences in substrate range and structural fold. These convergences hint at overarching principles governing the transport of amphipathic molecules across membranes, where multiple intermediate binding poses permit controlled solute passage while accommodating molecular complexity.

From a broader perspective, the identification of SLC35B1 as the gatekeeper for ATP entry into the ER opens compelling questions about the regulation of nucleotide supply during fluctuations in cellular energy status. Given the metabolic nexus between mitochondria—the principal site of ATP production—and the ER, elucidating potential feedback mechanisms controlling SLC35B1 activity represents a promising avenue for future research. Such regulatory insight could clarify how cells orchestrate energy distribution amidst diverse physiological demands and pathophysiological states.

Furthermore, since ATP-dependent chaperones and folding enzymes within the ER critically depend on a reliable ATP reservoir, the functional integrity of SLC35B1 likely influences proteostasis and the unfolded protein response. Dysregulation or mutations in this transporter could contribute to ER stress-related diseases, including metabolic disorders and neurodegenerative conditions, positioning SLC35B1 as a putative therapeutic target.

Methodologically, these findings exemplify the power of integrating cryo-electron microscopy with biochemical kinetics and genetic perturbation to dissect membrane transporter function at atomic resolution. Visualizing nucleotide-binding conformations and gating helix rearrangements in multiple transport states has been pivotal in constructing a dynamic mechanistic model that reconciles structure with function. Such comprehensive strategies herald a new era of transporter biology capable of unraveling the nuances of intracellular metabolite flux.

In summation, the elucidation of human SLC35B1 as a stepwise ATP translocator into the ER represents a landmark in membrane transport research. This work not only advances the fundamental biochemical understanding of nucleotide trafficking but also enriches our grasp of cellular energy economies and organelle interplay. The mechanistic revelations and physiological implications emerging from these discoveries will undoubtedly inspire further explorations into the intricacies of membrane transport and its impact on cellular health and disease.

Subject of Research: ATP translocation into the endoplasmic reticulum mediated by the human SLC35B1 transporter.

Article Title: Stepwise ATP translocation into the endoplasmic reticulum by human SLC35B1.

Article References:
Gulati, A., Ahn, D.H., Suades, A. et al. Stepwise ATP translocation into the endoplasmic reticulum by human SLC35B1. Nature (2025). https://doi.org/10.1038/s41586-025-09069-w

Image Credits: AI Generated